Metraipolis › archive › dc_08ee7cbb41d0
Cycloastragenol in inflammation-related diseases: mechanisms, pharmacokinetics, and translational prospects — Europe PMC PMID:41601951
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41601951
- DOI
- 10.3389/fphar.2025.1732996
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T21:19:07.093Z
- SHA-256 of the archived text
3a8698ccb39f8c0babf7c05df7daa9a7de8ca34876482bd646d9e678be6819a6- Stable URL of this page
https://metraipolis.com/documento/dc_08ee7cbb41d0
How to cite
Cycloastragenol in inflammation-related diseases: mechanisms, pharmacokinetics, and translational prospects — Europe PMC PMID:41601951 — Europe PMC (en), https://europepmc.org/article/MED/41601951 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_08ee7cbb41d0 (Metraipolis archive dc_08ee7cbb41d0, sha256 3a8698ccb39f8c0babf7c05df7daa9a7de8ca34876482bd646d9e678be6819a6)
BibTeX
@misc{dc08ee7cbb41d0,
title = {Cycloastragenol in inflammation-related diseases: mechanisms, pharmacokinetics, and translational prospects — Europe PMC PMID:41601951},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41601951},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_08ee7cbb41d0; sha256 3a8698ccb39f8c0babf7c05df7daa9a7de8ca34876482bd646d9e678be6819a6},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41601951. Agents can read the archived copy with the MCP tool read_document.